1 / 9

Asia-Pacific Anti-inflammatory Therapeutics Market 2014-2020

The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Get more details at: http://www.apacmarket.com/top-market/anti-inflammatory-therapeutics-market

apacmarket
Download Presentation

Asia-Pacific Anti-inflammatory Therapeutics Market 2014-2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Anti-inflammatory Therapeutics Asia-Pacific Market Research Report 2014-2020 Published Date: 30-Jun-2015 No. Pages : 130

  2. Report Description The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Moreover, increasing awareness of anti-inflammatory biologics and favorable government initiatives in the Asia-Pacific region are expected to drive the market during the analysis period. Factors, such as side effects of anti-inflammatory drugs and uncertain patent legislations, i.e., compulsory licensing in India would continue to impede the market growth. The Asia-Pacific anti-inflammatory therapeutics market is segmented on the basis of indication, drug class and geography.

  3. Report Description Among indications, arthritis was the dominant segment accounting for 41.3% of the APAC anti-inflammatory therapeutics market in 2014 and holds potential for growth during the forecast period. Anti-inflammatory biologics are the most preferred drugs for treatment of arthritis.  On the basis of drug class, the market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Anti-inflammatory biologics holds the largest share among drug classes accounting for around 50% share of the Asia-Pacific anti-inflammatory therapeutics market, and is expected to grow rapidly during the forecast period. Geographically, the market is segmented into six countries namely Japan, China, India, Australia, South Korea, Indonesia and others. 

  4. Report Description Among these countries, Japan holds the largest share in the Asia-Pacific anti-inflammatory therapeutics market; however, China is expected to exhibit the fastest growth during the forecast period. In 2014, Novartis got marketing approval for the drug Cosentyx (secukinumab) in Japan for the treatment of psoriatic arthritis. The company has filed new patents to overcome the issues of patent expiries of their existing drugs and to gain a prominent market share. The key companies profiled in this report are Pfizer, Inc., AbbVie, Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & CO., Inc., Novartis AG, F. Hoffmann-La Roche AG, Eli Lily and Company, AstraZeneca PLC and Amgen.

  5. Key Market Benefits • The report provides a quantitative analysis of the current market and estimations during 2014–2020 that assist in identifying and capitalizing on the prevailing market opportunities • Exhaustive analysis of the Asia-Pacific anti-inflammatory therapeutics market by product type helps in understanding the types of therapeutics and their categories that are currently being used to gain prominence in future • Competitive intelligence of leading manufacturers and distributors of anti-inflammatory therapeutics helps in understanding the competitive scenario across the geographies • Comprehensive analysis of factors that drive and restrict the growth of the Asia-Pacific anti-inflammatory therapeutics market has been provided

  6. Key Market Segments

  7. Market - By Country

  8. Table of Content Chapter 1    Introduction Chapter 2    Executive Summary Chapter 3    Market Overview Chapter 4 Asia-pacific Anti-inflammatory Therapeutics Market By Indication Chapter 5  Asia-pacific Anti-inflammatory Therapeutics Market By Drug Class Chapter 6  Asia-pacific Anti-inflammatory Therapeutics Market By Country Chapter 7    Company Profiles

  9. FOR MORE DETAILS Visit us at : http://www.apacmarket.com/top-market/anti-inflammatory-therapeutics-market Stay With Us: • TELEPHONE: +61-280 454 214 • EMAIL:  help@apacmarket.com

More Related